Catalym
John Haurum serves as the Chairman of the Board of Directors at CatalYm. In addition, John is a non-executive director of Agomab, Neophore, Synact, SynKlino and Storm. Previously, John served as CEO of F-star Therapeutics in Cambridge, England, and held the position of Vice President, Research at ImClone Systems. He also co-founded and served as the CSO of Symphogen, Denmark. He holds a D.Phil. in Immunology from The University of Oxford and an MD from Aarhus University, Denmark.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Catalym
Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.